Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Danish biopharma giant Novo Nordisk (NOV: N) is breaking new ground with its GLP-1 agonist semaglutide, as a small mid-stage ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

An advert for the company’s power stretch denim leggings has been banned by the Advertising Standards Agency (ASA) for the ...

Anne-Marie Zanzal, 60, and her wife Tonda McKay, 62, have also experienced the more positive changes that weight-loss drugs ...

An advert for the company’s power stretch denim leggings has been banned by the Advertising Standards Agency (ASA) for the ...

Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...

Dr. Maya Green discusses HIV prevention, U=U, and the importance of regular testing, particularly addressing disparities affecting Black women in healthcare.

From school meals to food labelling standards, contributors to our mini-series on Cayman's obesity crisis highlight a range ...

Discover the best sectors for growth stocks in the next decade. Explore which sectors may present an opportunity to bolster ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Beauty and Cosmetic Surgery Guide, Anna Pasternak reveals why society’s most refined faces are signing up for a more mindful ...